Any current/future capex/capital investment/strategic investment?

Currently undertaking CAPEX of about Rs. 4-5 crore: Rs. 2.5 crore for plant debottlenecking and Rs. 1.5 crore for effluent treatment plant to increase capacity by 25-30% without new plant investment. Future CAPEX planned to set up a new plant within the same premises for manufacturing two new products; work on this to start sometime next year. Considering new manufacturing capacities to scale beyond 25-30% growth; currently in development phase. Potential Rs. 20-25 crore large CAPEX for contract manufacturing if undertaken, but requires new facility. Strategic focus on expanding technical prod

Future growth expectations in sales/revenue/volumes?

Current capacity allows for 25-30% growth through de-bottlenecking investments without major CAPEX. Additional CAPEX of around Rs. 4-5 crore planned to increase capacity by 25-30%. Beyond that, new plant investments planned to support new products like Bifenthrin and two others in the pipeline, expected to commercialize in 2-3 years. Bifenthrin volumes expected to scale up materially once registrations in Americas (North & South) are approved. Focus shifting towards higher margin Technical and Branded Formulations, reducing bulk B2B sales. Exports currently ~60% of revenue, expected to remain

Future growth expectations in earnings/operating earnings/profits/EPS?

Expected 25-30% growth from current capacity after de-bottlenecking, without major CAPEX. New plant investment planned for manufacturing two new products, which will drive further topline growth. New product Bifenthrin has high margin potential, expected operating margins better than Chlorpyrifos, safely above 10%. Two more products (an insecticide and a herbicide) are in pipeline, with commercialization expected in 2-3 years. Gross margins expected to improve due to shift from bulk formulated product to higher-margin technical and branded formulations. Operating margins projected to rise abov

Current/ Expected Orderbook/ Pending Orders?

The company is currently in the development phase for new products and capacities. They have started production of a new product, Bifenthrin, but volume scale-up depends on awaiting registration approvals. Registrations are underway in North and South America; volumes will build up once approvals are received. The company anticipates 25-30% growth from current capacity with ongoing de-bottlenecking investments. For further growth beyond 30%, new manufacturing capacity investments are planned. Contract manufacturing discussions are ongoing, but no capacity available currently; new facility woul

Aimco Pesticides LtdQ1 FY21Fertilizers & Agrochemicals

Aimco Pesticides Ltd Q1 FY21 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹39.24Market Cap: ₹38 CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

Yes

Order

N/A

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

Current capacity allows for 25-30% growth through de-bottlenecking investments without major CAPEX.
Additional CAPEX of around Rs. 4-5 crore planned to increase capacity by 25-30%.
Beyond that, new plant investments planned to support new products like Bifenthrin and two others in the pipeline, expected to commercialize in 2-3 years.
Bifenthrin volumes expected to scale up materially once registrations in Americas (North & South) are approved.
Focus shifting towards higher margin Technical and Branded Formulations, reducing bulk B2B sales.
Exports currently ~60% of revenue, expected to remain stable with potential 5-7% variation.
Target to achieve ~Rs. 100 crore turnover in Technicals within 2 years.
Overall vision is consistent substantial growth, improved profit margins, and becoming a large production-based company with new generic molecules.

Margin guidance

Category 1

Expected 25-30% growth from current capacity after de-bottlenecking, without major CAPEX.
New plant investment planned for manufacturing two new products, which will drive further topline growth.
New product Bifenthrin has high margin potential, expected operating margins better than Chlorpyrifos, safely above 10%.
Two more products (an insecticide and a herbicide) are in pipeline, with commercialization expected in 2-3 years.
Gross margins expected to improve due to shift from bulk formulated product to higher-margin technical and branded formulations.
Operating margins projected to rise above current 10%, aided by new products and better market conditions.
Capacity expansion and registration approvals critical for scaling up sales and profitability in exports.
The company targets consistent growth and margin improvement over next 3-5 years, focusing on new molecules and export markets.

See what Aimco Pesticides Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

- The company raised Rs. 4 crore term loan and Rs. 6 crore working capital loan recently to enhance working capital and support capital investment. - The promoter shareholding was pledged as security for this debt. - There is no indication of immediate further fundraising through debt or equity mentioned. - Future capital expenditures are planned, including about Rs. 2.5 crore on plant de-bottlenecking and Rs. 1.5 crore on effluent treatment, and a new plant investment starting next year for new products. - No explicit mention of additional fundraising for these future CAPEX; current funds and working capital loans appear to cover these. - The company plans to manage working capital prudently and does not intend to carry promoter pledges long-term. In summary, the company has recently taken some debt but no clear plans for new fundraising through debt or equity were stated for the near future.

Order book

The company is currently in the development phase for new products and capacities.
They have started production of a new product, Bifenthrin, but volume scale-up depends on awaiting registration approvals.
Registrations are underway in North and South America; volumes will build up once approvals are received.
The company anticipates 25-30% growth from current capacity with ongoing de-bottlenecking investments.
For further growth beyond 30%, new manufacturing capacity investments are planned.
Contract manufacturing discussions are ongoing, but no capacity available currently; new facility would require separate CAPEX (~Rs. 20-25 crore).
The order book is thus linked closely to registration status and market conditions, with expected growth driven by new products' commercialization and capacity expansion.

See what Aimco Pesticides Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Currently undertaking CAPEX of about Rs. 4-5 crore: Rs. 2.5 crore for plant debottlenecking and Rs. 1.5 crore for effluent treatment plant to increase capacity by 25-30% without new plant investment.
Future CAPEX planned to set up a new plant within the same premises for manufacturing two new products; work on this to start sometime next year.
Considering new manufacturing capacities to scale beyond 25-30% growth; currently in development phase.
Potential Rs. 20-25 crore large CAPEX for contract manufacturing if undertaken, but requires new facility.
Strategic focus on expanding technical product sales and branded formulations with new products in pipeline.
Actively investing upfront in product registrations required for exports across various countries.

Track Aimco Pesticides Ltd — get its next earnings analysis in your feed

How does Aimco Pesticides Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisAimco Pesticides Ltd

Rev 2Mar 1

See where Aimco Pesticides Ltd sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Aimco Pesticides Ltd rank in Fertilizers & Agrochemicals?

Compare Aimco Pesticides Ltd against every Fertilizers & Agrochemicals company (Q1 FY21) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What Aimco Pesticides Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Dhanuka Agritech Ltd (Q2 FY27)
657.51 Crores . Key investor presentation takeaways from Dhanuka Agritech Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.
Sharda Cropchem Ltd (Q2 FY27)
1,051.7 Cr, up 13% YoY (Q2 FY26: Rs. Key investor presentation takeaways from Sharda Cropchem Ltd's Q2 FY27 investor presentation — and how it ranks against sec
Paradeep Phosphates Ltd (Q2 FY27)
Revenue from operations for the quarter ended 30 September 2026: Rs 7,164.06 crores . Key results statement takeaways from Paradeep Phosphates Ltd's Q2 FY27 ear
Astec Lifescienc (Q2 FY27)
2.3% YoY decline. Key results statement takeaways from Astec Lifescienc's Q2 FY27 results statement — and how it ranks against sector peers.

Compare:vs Coromandel Inter vs UPL Ltd vs F A C T

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →